Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: MRS Rhiannon Roberts

Back to Search
Oscanoa J, Ross-Adams H, Ullah AZMD, Kolvekar TS, Sivapalan L, Gadaleta E, Thorn GJ, Abdollahyan M et al. ( 2025 ) . A central research portal for mining pancreatic clinical and molecular datasets and accessing biobanked samples . Translational Oncology vol. 62 ,
Kocher HM, Davidson B, Isherwood J, Robinson SM, Soonawalla Z, Tanno L, Bhattacharya S, Al-Sarireh B et al. ( 2025 ) . The Pancreas Tissue Bank (PCRFTB): Global facilitation of pancreatic research . Journal of Clinical Oncology vol. 43 , ( 16_suppl ) e16416 - e16416 .
Kocher HM, Davidson B, Isherwood J, Robinson S, Soonawalla Z, Tanno L, Bhattacharya S, al-Sarireh B et al. ( 2025 ) . Abstract 5930: The Pancreas Tissue Bank (PCRFTB): Global facilitation of pancreatic research . Cancer Research vol. 85 , ( 8_Supplement_1 ) 5930 - 5930 .
Zardab M, Grose RP, Kocher HM ( 2025 ) . AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility . Scientific Reports vol. 15 , ( 1 )
Kocher HM, Sasieni P, Corrie P, McNamara MG, Sarker D, Froeling FEM, Christie A, Gillmore R et al. ( 2025 ) . Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2 . BMC Cancer vol. 25 , ( 1 )
Zardab M, Balarajah V, Banerjee A, Stasinos K, Saad A, Imrali A, Hughes C, Roberts R et al. ( 2022 ) . Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study . Cancers vol. 15 , ( 1 )
Debernardi S, O’Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, Costello E, Greenhalf W et al. ( 2020 ) . A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study . PLOS Medicine vol. 17 , ( 12 )
Kocher HM, Basu B, Froeling FE, Sarker D, Slater S, Carlin D, deSouza NM, De Paepe KN et al. ( 2020 ) . STARPAC clinical trial . Pancreatology vol. 20 , ( 8 )
Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, deSouza NM, De Paepe KN et al. ( 2020 ) . Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer . Nature Communications vol. 11 , ( 1 )
Schilling K, Larner F, Saad A, Roberts R, Kocher HM, Blyuss O, Halliday AN, Crnogorac-Jurcevic T ( 2020 ) . Urine metallomics signature as an indicator of pancreatic cancer† . Metallomics vol. 12 , ( 5 ) 752 - 757 .
Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, Coetzee C, de Souza N et al. ( 2019 ) . 700P STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer . Annals of Oncology vol. 30 ,
Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, Coetzee C, de Souza N et al. ( 2019 ) . STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer . ANNALS OF ONCOLOGY . vol. 30 ,
Oscanoa J, Ross-Adams H, Ullah AZMD, Kolvekar TS, Sivapalan L, Gadaleta E, Thorn GJ, Abdollahyan M et al. . A central research portal for mining pancreatic clinical and molecular datasets and accessing biobanked samples .
Zardab M, Balarajah V, Banerjee A, Stasinos K, Saad A, Imrali A, Hughes C, Roberts R et al. . Development of a Model for Differentiating PDAC from Benign Pancreatic Conditions: A Prospective Case-control Study .
Back to Search